These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 8233444)

  • 41. [Bone alkaline phosphatase as an activity parameter of acromegaly].
    Hampel R; Rose HJ; Jahreis G; Krabbe S; Meng W; Hesse V
    Dtsch Med Wochenschr; 1990 Mar; 115(10):363-6. PubMed ID: 2311510
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Growth hormone, body composition and somatomedin C after treatment of acromegaly.
    McLellan AR; Connell JM; Beastall GH; Teasdale G; Davies DL
    Q J Med; 1988 Dec; 69(260):997-1008. PubMed ID: 3270086
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Relationship between disease-related morbidity and biochemical markers of activity in patients with acromegaly.
    Puder JJ; Nilavar S; Post KD; Freda PU
    J Clin Endocrinol Metab; 2005 Apr; 90(4):1972-8. PubMed ID: 15634715
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Discrepancy between IGF-1 and GH during 75 g oral glucose tolerance test measures to acromegaly screening in a patient with macroprolactinoma--case report and literature review].
    Gonçalves FT; Feibelmann TC; Fernandes ML; Fonseca AR; Arantes HP; Jorge PT
    Arq Bras Endocrinol Metabol; 2007 Apr; 51(3):494-9. PubMed ID: 17546251
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serum IGF-1 in the diagnosis of acromegaly and the profile of patients with elevated IGF-1 but normal glucose-suppressed growth hormone.
    Subbarayan SK; Fleseriu M; Gordon MB; Brzana JA; Kennedy L; Faiman C; Hatipoglu BA; Prayson RA; Delashaw JB; Weil RJ; Hamrahian AH
    Endocr Pract; 2012; 18(6):817-25. PubMed ID: 22784832
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical features and natural course of acromegaly in patients with discordance in the nadir GH level on the oral glucose test and the IGF-1 value at 3 months after adenomectomy.
    Kinoshita Y; Tominaga A; Usui S; Arita K; Sakoguchi T; Sugiyama K; Kurisu K
    Neurosurg Rev; 2016 Apr; 39(2):313-8; discussion 318-9. PubMed ID: 26785642
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The challenges of reliance on insulin-like growth factor I in monitoring disease activity in patients with acromegaly.
    Paisley AN; Trainer PJ
    Horm Res; 2004; 62 Suppl 1():83-8. PubMed ID: 15761238
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [CLINICAL, BIOCHEMICAL AND HORMONAL PREDICTORS OF LEFT VENTRICULAR HYPERTROPHY IN PATIENTS WITH ACROMEGALY].
    Mykytyuk MR
    Lik Sprava; 2015; (5-6):34-40. PubMed ID: 27089713
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Growth hormone (GH) and IGF-I assays: methodological aspects and its implications in acromegaly diagnosis and follow-up].
    Casagrande A; Czepielewski MA
    Arq Bras Endocrinol Metabol; 2007 Jun; 51(4):511-9. PubMed ID: 17684610
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Measurement of salivary insulin-like growth factor-I in acromegaly: comparison with serum insulin-like growth factor-I and growth hormone concentrations.
    Halimi S; Tepavcević D; Suchanek D; Giljević Z; Palvsić V; Korsić M
    Eur J Clin Chem Clin Biochem; 1994 Sep; 32(9):705-7. PubMed ID: 7865627
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly.
    Holdaway IM; Bolland MJ; Gamble GD
    Eur J Endocrinol; 2008 Aug; 159(2):89-95. PubMed ID: 18524797
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The imbalance of cathepsin B-like activity in acromegalic patients--preliminary report.
    Daroszewski J; Bolanowski M; Kaluzny M; Siewinski M
    Neuro Endocrinol Lett; 2010; 31(2):256-60. PubMed ID: 20424577
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Visceral adiposity index is associated with insulin sensitivity and adipocytokine levels in newly diagnosed acromegalic patients.
    Ciresi A; Amato MC; Pizzolanti G; Giordano Galluzzo C
    J Clin Endocrinol Metab; 2012 Aug; 97(8):2907-15. PubMed ID: 22679062
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Insulin-like growth factor I and daily growth hormone profile in the assessment of active acromegaly.
    Barreca A; Ciccarelli E; Minuto F; Bruzzi P; Giordano G; Camanni F
    Acta Endocrinol (Copenh); 1989 May; 120(5):629-35. PubMed ID: 2728807
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Elevated IGF-1 with GH suppression after an oral glucose overload: incipient acromegaly or false-positive IGF-1?
    Rosario PW; Calsolari MR
    Arch Endocrinol Metab; 2016; 60(6):510-514. PubMed ID: 27982199
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Effect of growth hormone on sleep energy].
    Aström CP; Trojaborg W
    Ugeskr Laeger; 1994 Oct; 156(40):5849-52. PubMed ID: 7985277
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of insulin-like growth factor (somatomedin) levels in acromegaly.
    Rieu M
    Horm Res; 1986; 24(2-3):112-5. PubMed ID: 3530936
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of tamoxifen on GH and IGF-I levels in acromegaly.
    Cozzi R; Attanasio R; Oppizzi G; Orlandi P; Giustina A; Lodrini S; Da Re N; Dallabonzana D
    J Endocrinol Invest; 1997 Sep; 20(8):445-51. PubMed ID: 9364247
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of growth hormone and insulin-like growth factor I on urinary albumin excretion: studies in acromegaly and growth hormone deficiency.
    Hoogenberg K; Sluiter WJ; Dullaart RP
    Acta Endocrinol (Copenh); 1993 Aug; 129(2):151-7. PubMed ID: 8372600
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A comparison of different methods for diagnosing acromegaly.
    Stoffel-Wagner B; Springer W; Bidlingmaier F; Klingmüller D
    Clin Endocrinol (Oxf); 1997 May; 46(5):531-7. PubMed ID: 9231047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.